Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy—results of a multicentric randomized German trial in advanced head-and-neck cancer

This publication has 33 references indexed in Scilit:

• META-ANALYSES IN HEAD AND NECK SQUAMOUS CELL CARCINOMA
  Hematology/Oncology Clinics of North America, 1999
• Hyperfractionated Irradiation with or without Concurrent Chemotherapy for Locally Advanced Head and Neck Cancer
  New England Journal of Medicine, 1998
• 47 Results of a German multicentric trial of accelerated hyperfractionated radiochemotherapy in advanced head and neck cancer
  Radiotherapy and Oncology, 1996
• 146Randomized clinical trial of accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on treatment toxicity
  Radiotherapy and Oncology, 1996
• 110Conventional radiotherapy as the primary treatment of squamous cell carcinoma (SCC) of the head and neck. A randomized multicenter study of 5 versus 6 fractions per week — Preliminary report from the Dahanca 6 and 7 trial
  Radiotherapy and Oncology, 1996
• Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)
  International Journal of Radiation Oncology*Biology*Physics, 1995
• Development of a European Organization for Research and Treatment of Cancer (Eortc) Questionnaire Module to be Used in Quality of Life Assessments in Head and Neck Cancer Patients
  Acta Oncologica, 1994
• Treatment of Advanced Squamous-Cell Carcinoma of the Head and Neck with Alternating Chemotherapy and Radiotherapy
  New England Journal of Medicine, 1992
• The linear-quadratic formula and progress in fractionated radiotherapy
  The British Journal of Radiology, 1989
• Accelerated Fractionation in the Radiation Treatment of Head and Neck Cancer—A Critical Comparison of Different Strategies
  Acta Oncologica, 1988